Pathfinder Acquisition Corp. (NASDAQ:PFDR) announced this morning that it has closed its combination with motion-capture technology company Movella.
The combined company will operate as “Movella Holdings Inc.”, and its common stock and warrants are expected to begin trading on the Nasdaq under the ticker symbol “MVLA” and “MVLAW”, respectively, on February 13.
Pathfinder shareholders approved the combination on February 8, but the SPAC noted that it would not close until today, February 10. Following the shareholder meeting, the SPAC disclosed that a total of 28,961,090 shares were redeemed in connection with the vote, removing 89.1% of its trust and leaving it with $36.2 million.
The transaction was supported by $75 million of financing from affiliates of Francisco Partners prior to closing through a direct placement of Pathfinder stock. Under the terms of the financing, Movella issued Francisco Partners a 5-year payment-in-kind note. This allows Movella the right to direct the sale of FP’s purchased stock at any time following the closing until the repayment of the note, the proceeds of which will provide credits against the note balance at a repayment or refinancing event.
Pathfinder initially announced its $537 million combination with Movella on October 4. San Jose, California-based Movella provides motion-capture hardware and software for the entertainment, health and manufacturing industries.
ADVISORS
- Pathfinder was advised by Kirkland & Ellis LLP.
- Movella was advised by Stifel (as an exclusive financial advisor).
- Pillsbury Winthrop Shaw Pittman LLP served as legal advisor in connection with the transaction.
- Francisco Partners was advised by Latham & Watkins LLP in connection with the transaction.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...